
We prioritize stringent quality control protocols, ensuring all research results are reliable and reproducible, aiding in faster regulatory pathways for respiratory diseases.
Our team comprises seasoned experts in respiratory disease research, enabling us to provide insightful guidance and innovative solutions for complex challenges faced in preclinical studies.
We offer flexible minimum order quantities, accommodating both large-scale and niche projects, ensuring that our CRO services are accessible to all research entities.
Our integrated services cover everything from toxicology to efficacy studies, providing a one-stop solution for preclinical research related to respiratory diseases.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china